Description
Anti-ERBB2 (Trastuzumab-LC-N152) -DBCO-MMAF ADC | ADC-W-255 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, LC-N152) conjugated via a DBCO linker to MMAF
Status: In stock
Expected Delivery Time: 9-11Weeks